Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Tissue Banks × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Thoracic Diseases 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prolactinoma 1 Pituitary ACTH Hypersecretion 1 Peritoneal Diseases 1 Paraproteinemias 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Diseases 1 Neuroblastoma 1 Nervous System Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lung Neoplasms 1 Leiomyosarcoma 1 Immunoglobulin Light-chain Amyloidosis 1 Hepatoblastoma 1 HER2 Positive Advanced Gastric Cancer 1 Gigantism 1

Interventions

Cyclophosphamide 81 Etoposide 44 Temozolomide 37 Carboplatin 37 Filgrastim 36 Topotecan 35 Melphalan 35 Isotretinoin 35 Irinotecan 35 Vincristine 34 Doxorubicin 33 3-Iodobenzylguanidine 30 Granulocyte Colony-Stimulating Factor 26 Cisplatin 25 Peripheral Blood Stem Cell Transplantation 24 sargramostim 21 dinutuximab 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 Radiotherapy 20 Busulfan 18 fludarabine 16 Magnetic Resonance Spectroscopy 16 naxitamab 14 aldesleukin 13 Thiotepa 13 Interleukin-2 13 fludarabine phosphate 12 humanized 3F8 anti-GD2 monoclonal antibody 11 etoposide phosphate 11 Biopsy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04239040 2025-03-19

GVAX Plus Checkpoint Blockade in Neuroblastoma

Dana-Farber Cancer Institute

Phase 1 Terminated

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡